This filing relates to the public offering of up to 1.62M shares of common stock of Bone Biologics Corporation by the selling stockholders. The company will not receive any of the proceeds from the sale of common stock by the selling stockholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBLG: